The second clinical case involved a carrier of the de novo NF1 gene mutation who was concurrently diagnosed with alveolar rhabdomyosarcoma (ARMS), juvenile xanthogranuloma, and gliomas located in the central nervous system (CNS), including in the optic nerve. Here, NF1 is linked to central nervous system cancer.